Prediction of subclinical left ventricular dysfunction by speckle-tracking echocardiography in patients with anti-neutrophil cytoplasmic antibody--associated vasculitis
- PMID: 35949862
- PMCID: PMC9326387
- DOI: 10.46497/ArchRheumatol.2022.8916
Prediction of subclinical left ventricular dysfunction by speckle-tracking echocardiography in patients with anti-neutrophil cytoplasmic antibody--associated vasculitis
Abstract
Objectives: This study aims to evaluate left ventricular functions using speckle-tracking echocardiography (STE) in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Patients and methods: Between June 2018 and July 2019, a total of 31 AAV patients (17 males, 14 females; median age: 53 years; range, 47 to 62 years) and 21 healthy controls (11 males, 10 females; median age: 56 years; range, 46 to 60 years) were included in the study. Clinical and biochemical characteristics of all participants were recorded. All participants underwent conventional and two-dimensional STE. The receiver operating characteristic (ROC) curve analysis was performed to determine the cut-off value of serum N-terminal prohormone of brain natriuretic peptide (NT-pro-BNP) that predicted subclinical left ventricular dysfunction. The Spearman correlation analysis was used to determine the correlation between left ventricular global longitudinal strain (LV-GLS) and NT-pro-BNP.
Results: The LV-GLS was lower in AAV patients (19.3% vs. 21.7%, respectively; p=0.014). NT-pro-BNP was negatively correlated with LV-GLS (p=0.005, r=0.401).
Conclusion: Subclinical left ventricular dysfunction can be detected by STE in patients with AAV who have free of clinically overt cardiovascular disease. The LV-GLS is negatively correlated with serum NT-pro-BNP levels.
Keywords: Anti-neutrophil cytoplasmic antibody-associated vasculitis; cardiovascular risk; speckle-tracking echocardiography; strain..
Copyright © 2022, Turkish League Against Rheumatism.
Conflict of interest statement
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Figures


Similar articles
-
Use of three-dimensional speckle-tracking echocardiography for quantitative assessment of global left ventricular function: a comparative study to three-dimensional echocardiography.J Am Soc Echocardiogr. 2014 Mar;27(3):285-91. doi: 10.1016/j.echo.2013.11.002. Epub 2013 Dec 8. J Am Soc Echocardiogr. 2014. PMID: 24325960
-
2-D speckle-tracking assessment of left and right ventricular function in rheumatoid arthritis patients with and without disease activity.J Saudi Heart Assoc. 2019 Jan;31(1):41-49. doi: 10.1016/j.jsha.2018.10.001. Epub 2018 Nov 16. J Saudi Heart Assoc. 2019. PMID: 30559579 Free PMC article.
-
Assessment of global longitudinal strain and plasma natriuretic peptide in patients with asymptomatic left ventricular dysfunction.Kardiologiia. 2021 Oct 30;61(10):53-60. doi: 10.18087/cardio.2021.10.n1692. Kardiologiia. 2021. PMID: 34763639
-
Serum levels of N-terminal-pro B-type natriuretic peptide as a diagnostic marker for left ventricular dysfunction in children with end-stage renal disease on hemodialysis.Saudi J Kidney Dis Transpl. 2016 Nov-Dec;27(6):1114-1122. doi: 10.4103/1319-2442.194593. Saudi J Kidney Dis Transpl. 2016. PMID: 27900955
-
Initial application of three-dimensional speckle-tracking echocardiography to detect subclinical left ventricular dysfunction and stratify cardiomyopathy associated with Duchenne muscular dystrophy in children.Int J Cardiovasc Imaging. 2019 Jan;35(1):67-76. doi: 10.1007/s10554-018-1436-8. Epub 2018 Aug 13. Int J Cardiovasc Imaging. 2019. PMID: 30105418
References
-
- Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11. - PubMed
-
- Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med. 2004;117:39–50. - PubMed
-
- Mahr A, Katsahian S, Varet H, Guillevin L, Hagen EC, Höglund P, et al. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: A cluster analysis. Ann Rheum Dis. 2013;72:1003–1010. - PubMed
-
- Morgan MD, Turnbull J, Selamet U, Kaur-Hayer M, Nightingale P, Ferro CJ, et al. Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: A matched-pair cohort study. Arthritis Rheum. 2009;60:3493–3500. - PubMed
-
- Flossmann O. Risks of treatments and long-term outcomes of systemic ANCA-associated vasculitis. e251-7Presse Med. 2015;44 - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous